Saltar al contenido
Merck

HPLC Analysis of a Peptide Drug on Antibodix® WCX-NP10, Gradient Optimization to Separate Impurity

HPLC Analysis of a Peptide Drug on Antibodix® WCX-NP10, Gradient Optimization to Separate Impurity application for HPLC

Materiales

Analytical column

Referencia del producto
Descripción
Precios

Antibodix® WCX-NP10 Weak Cation Exchange Column

L × I.D. 25 cm × 4.6 mm, 10 μm particle size

Antibodix® WCX-NP10 Weak Cation Exchange Column

L × I.D. 25 cm × 4.6 mm, 10 μm particle size, PEEK

CONDITIONS

column

Antibodix WCX-NP10, 25 cm x 4.6 mm I.D., 10 μm particles (Z777272)

mobile phase

[A] 3 mM potassium phosphate, pH 5.0; [B] 20 mM potassium phosphate, pH 7.5

gradient

(A) 0% - 50% B (20 min); (B) 0% - 20% B (20 min), 20% B after 20 min

flow rate

1 mL/min

column temp.

ambient

detector

injection

5 μL

sample

2 mg/mL, proprietary peptide drug, pI 7-8

Descripción

Legal Information

Antibodix is a registered trademark of Sepax Technologies